News

Reportedly, the Diocese of Sunyani will be the sole distributor for all drugs manufactured by AGP Ghana. The partnership will allow priority access to Catholic Mission Hospitals in

Victoza is a once-daily human GLP-1 analogue for the treatment of type 2 diabetes. The price approval allows Novo Nordisk to launch in Japan shortly after Victoza is

Medidata has started ASPire to Win in April 2005, as a channel partner program designed to enable select CROs and other service providers to offer Medidata Rave implementation

Reportedly, the DEA has officially lifted the restrictions against the use of electronic prescribing for controlled substances (schedule II – schedule V), which have been the single greatest

Under the contract with ProBioGen, AFFiRiS is expected to evaluate HuALN technology as a human organoid model to investigate drug-related effects in the context of the human immune

The agreement grants Taconic a worldwide, non-exclusive license to use various patented AvGFP variants in the generation and commercialisation of genetically modified rodent models. AvGFP technology also can

Akela Pharma has posted a net income of $14.06m, or $0.46 per diluted share, compared $13.6m, or $0.63 per diluted share, for the prior year period. For the

In the trial, NCX 434 has improved oxygen saturation in the eye. The effects of intravitreal injections of NCX 434 or triamcinolone, a reference steroid, on oxygen saturation

Axanum is a fixed-dose combination containing low-dose ASA (acetylsalicylic acid) and the active ingredient of the PPI Nexium developed by AstraZeneca for the prevention of cardio- and cerebrovascular